Nifty99000 100%

Sensex99000 100%

Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
RSS

News

Trade deficit with India decreased in 2017; concerned over trade barriers: US

Author: PTI/Thursday, April 5, 2018/Categories: Economy

Trade deficit with India decreased in 2017; concerned over trade barriers: US

By Lalit K Jha

Washington, April 5 - The trade deficit between India and the US dropped by almost 6% in 2017 compared to the previous year, the US Trade Representative (USTR) has said, even as it continued to harp on issues such as market access and high tariffs on several American products being imported into India.

"The US goods trade deficit with India was USD 22.9 billion in 2017, a 5.9% decrease (USD 1.4 billion) over 2016," said the National Trade Estimate 2018 released by the USTR. India is one of the few countries with which US' trade deficit has decreased in the last one year.

US goods exports to India were USD 25.7 billion, up 18.7% (USD 4.0 billion) from the previous year. The corresponding US imports from India were USD 48.6 billion, up 5.6%. India was the US' 15th largest goods export market in 2017, the annual report said.

Similarly, US exports of services to India were an estimated USD 23.1 billion in 2017 and US imports were USD 28.7 billion. Sales of services in India by majority US-owned affiliates were USD 24.5 billion in 2015 (latest data available), while sales of services in the United States by majority India-owned firms were USD 14.7 billion, the voluminous report said.

US foreign direct investment (FDI) in India (stock) was USD 32.9 billion in 2016 (latest data available), a 10% increase from 2015. US direct investment in India is led by prof., scientific, and tech. services, manufacturing, and wholesale trade, it said.

However, the Trump administration continued to harp India on a number of issues, including market access, high tariff and protection of intellectual property.

"In 2017, India implemented price controls on coronary stents and knee implants that do not fully differentiate for advanced technologies within a product class," it said.

National US companies have applied to withdraw technologically advanced products from the market, but the requests have been rejected, forcing the US to sell certain products at a loss. India has indicated it may apply similar price controls on additional medical devices, it said.

According to National Trade Estimate, India continues to maintain some of the highest average tariff rates worldwide.  The large gap between India's WTO bound and applied tariff rates allows India to make frequent adjustments to the level of protection provided to domestic producers by modifying tariff rates, it said.

For example, in 2017 India increased tariffs on pulses from zero to 30 and 50%. India also raised tariffs on certain high-tech information and communication technology products from zero to between 10 and 20%. The US companies have raised significant concerns with these actions, it alleged.

"The United States continues to raise these concerns through bilateral engagement with the Indian government, including through the US-India Trade Policy Forum," the USTR said.

According to the report, the US has actively sought bilateral and multilateral opportunities to open India's market, and the government of India has pursued ongoing economic reform efforts. Nevertheless, US exporters continue to encounter tariff and nontariff barriers that impede imports of US products into India, it said.

Noting that India imposes onerous requirements on dairy imports, the report said India continues to require that dairy products be derived from animals which have never consumed any feeds containing internal organs, blood meal, or tissues of ruminant origin.

India has explained that its position is based on religious and cultural grounds, it said. This requirement, along with high tariff rates, continues to prevent market access for US milk and dairy product exports to India, one of the largest dairy markets in the world.

"In order to address India's religious and cultural concerns, in 2015, the US proposed a labelling solution to allow for consumer choice between dairy products derived from animals that have or have not consumed feeds with ruminant protein," the USTR said.

India has so far rejected that proposal, and the US continues to press India to provide access to the Indian dairy market, the report claimed.

The US, it said, has raised concerns about India's sanitary and phytosanitary (SPS)-related trade restrictions in bilateral and multilateral fora including the TPF, the WTO SPS Committee, and Codex.

According to the report, the US continues to work with India to open market access for US poultry products into India consistent with the WTO ruling. Until then, the US considers the dispute unresolved, it said.

Observing that India maintains zero tolerance standards for certain plant quarantine pests, such as weed seeds and ergot, that are not based on risk assessments and result in blocked imports of US wheat and barley, the report said bilateral discussions to resolve these issues, including at the senior official level, have achieved little success to date.

Print Rate this article:
No rating

Number of views (60)/Comments (0)

rajyashree guha

PTI

Other posts by PTI
Contact author

Leave a comment

Name:
Email:
Comment:
Add comment

Name:
Email:
Subject:
Message:
x

Videos

Ask the Finapolis.

I'm not a robot
 
Dharmendra Satpathy
Col. Sanjeev Govila (retd)
Hum Fauji Investments
 
The Finapolis' expert answers your queries on investments, taxation and personal finance. Want advice? Submit your Question above
Want to Invest
 
 

Categories

Disclaimer

The technical studies / analysis discussed here can be at odds with our fundamental views / analysis. The information and views presented in this report are prepared by Karvy Consultants Limited. The information contained herein is based on our analysis and upon sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither Karvy nor Karvy Consultants nor any person connected with any associate companies of Karvy accepts any liability arising from the use of this information and views mentioned in this document. The author, directors and other employees of Karvy and its affiliates may hold long or short positions in the above mentioned companies from time to time. Every employee of Karvy and its associate companies is required to disclose his/her individual stock holdings and details of trades, if any, that they undertake. The team rendering corporate analysis and investment recommendations are restricted in purchasing/selling of shares or other securities till such a time this recommendation has either been displayed or has been forwarded to clients of Karvy. All employees are further restricted to place orders only through Karvy Consultants Ltd. This report is intended for a restricted audience and we are not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities.

Subscribe For Free

Get the e-paper free